Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma

Código QR

Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma

Yuya Nomura1, Shunsuke Nakakura2, Mitsuyasu Moriwaki1, Yasuhiro Takahashi1, Kunihiko Shiraki11Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka City University, Japan; 2Department of Ophthalmology, Saiseikai Gose Hospital, JapanPurpose: The effect of travoprost 0.00...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yuya Nomura, Shunsuke Nakakura, Mitsuyasu Moriwaki, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/b8f4cc3346f24a1c8c0d6265ab354a9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Travoprost with sofZia® preservative system lowered intraocular pressure of Japanese normal tension glaucoma with minimal side effects
por: Mizoue S, et al.
Publicado: (2014)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
por: Yoshimi Nakamura, et al.
Publicado: (2009)

The diurnal and nocturnal effects of travoprost in normal-tension glaucoma
por: Seibold LK, et al.
Publicado: (2014)

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma
por: Lee JWY, et al.
Publicado: (2015)

Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
por: Inoue K, et al.
Publicado: (2012)

Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
por: Quaranta L, et al.
Publicado: (2015)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events
por: Tsumura T, et al.
Publicado: (2012)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2012)

Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events. [Corrigendum]
por: Tsumura T, et al.
Publicado: (2013)

Individualized Significance of 24-Hour Intraocular Pressure Curves for Therapeutic Decisions in Primary Chronic Open-Angle Glaucoma Patients
por: Lever M, et al.
Publicado: (2020)

Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%
por: Dubiner HB, et al.
Publicado: (2012)

Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
por: Mizoguchi T, et al.
Publicado: (2011)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda Y, et al.
Publicado: (2016)

Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis
por: M Kamio, et al.
Publicado: (2009)

Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population
por: Perera SA, et al.
Publicado: (2016)

The clinical effectiveness of tafluprost on Japanese normal-tension glaucoma patients
por: Nomura A, et al.
Publicado: (2018)

Association of microsatellite polymorphisms of the GPDS1 locus with normal tension glaucoma in the Japanese population
por: Kayo Nakamura, et al.
Publicado: (2009)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
por: Miguel A Teus, et al.
Publicado: (2009)

Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients
por: Mohammed K El Mallah, et al.
Publicado: (2010)

Optic disc topography in Malay patients with normal-tension glaucoma and primary open-angle glaucoma
por: Adlina AR, et al.
Publicado: (2014)

Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma
por: Chandra P, et al.
Publicado: (2011)

First experience with BAK-free travoprost 0.004% in topical glaucoma medication
por: Gado AS, et al.
Publicado: (2011)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori N, et al.
Publicado: (2021)

Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma
por: Inoue K, et al.
Publicado: (2013)

Serum free fatty acids levels not associated with normal tension glaucoma
por: Kenya Yuki, et al.
Publicado: (2010)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto D, et al.
Publicado: (2017)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock M, et al.
Publicado: (2015)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Gregory Katz, et al.
Publicado: (2010)

Twenty-four-hour intraocular pressure patterns in a symptomatic patient after ab interno trabeculotomy surgery
por: Mansouri K, et al.
Publicado: (2014)

Superior segmental optic nerve hypoplasia accompanied by progressive normal-tension glaucoma
por: Yamazaki Y, et al.
Publicado: (2012)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost&ndash;timolol, bimatoprost/bimatoprost&ndash;timolol, and travoprost/travoprost&ndash;timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
por: Antoine Lafuma, et al.
Publicado: (2011)

Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey
por: Jean-Philippe Nordmann, et al.
Publicado: (2010)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
por: Nakano T, et al.
Publicado: (2016)

Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma
por: Liu Y, et al.
Publicado: (2012)

Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
por: Emilio Rintaro Suzuki Jr, et al.
Publicado: (2010)

Effects of treatment with bimatoprost 0.03% for 3 years in patients with normal-tension glaucoma
por: Inoue K, et al.
Publicado: (2014)

Efficacy of preservative-free tafluprost in patients with normal-tension glaucoma previously treated with latanoprost
por: Sacchi M, et al.
Publicado: (2014)

Optic disc size and progression of visual field damage in patients with normal-tension glaucoma
por: Hayamizu F, et al.
Publicado: (2013)

The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
por: Nakamoto K, et al.
Publicado: (2018)

Corrigendum: Efficacy and safety of travoprost alone or in combination with other agents for glaucoma and ocular hypertension: patient considerations
por: Suzuki CLB, et al.
Publicado: (2010)